The change of name is a contractual requirement of its divestment from TTP Group in 2018 with the backing of technology-focused investment firm Battery Ventures
The method, called 'scPred,' has the potential to allow earlier detection of cancer, identify the cells at the root of autoimmune disease, and help personalize treatments to individual patients
Princeton researchers have developed new computational and experimental tools to identify microbial small molecules encoded in clinical samples, allowing scientists to explore microbial-host interactions and to mine the human microbiome for drug discovery